Latinas participating in an educational intervention program were two-and-a-half times more likely to seek postpartum care than were those who did not have access to a similar program, a new study finds.
Although 80 percent of women with private insurance receive related health care after having a baby, only 59 percent of women with Medicaid insurance do, according to the Health Employer Data and Information Set (HEDIS). Women of low income, particularly Latinas and other minorities, have greater health risks due to below-average rates of postpartum follow-up visits, the authors write.
"Having patients come back for postpartum checkups is very important," said lead study author Flavio Marsiglia, Ph.D., the director of the Southwest Interdisciplinary Research Center (SIRC) at the School of Social Work at Arizona State University. "It is during this time that some health and mental problems, such as depression, may be recognized."
The study relied on the Familias Sanas, or Healthy Families, program and examined postpartum visit rates and other wellbeing measures. It appears in the August issue of the Journal of Health Care for the Poor and Underserved.
During a first prenatal visit, researchers invited women to participate in the randomized controlled study if they were less than 34 weeks pregnant, at least 18 years old and identified their ethnicity as Latina or Hispanic. The women each met between five and 20 times with a bicultural and bilingual prenatal partner a student in the social work program.
Among other things, the prenatal partner conducted a baseline assessment, provided education, assisted with communication and helped arrange regular prenatal and postpartum visits.
The study included 440 women seen at the Women's Care Clinic at Maricopa Medical Center in Phoenix. Of these, 221 women participated in the intervention and 219 were in the control group. Eighty-four percent of participants were first-generation immigrants and 73 percent had an annual income of less than $20,000. Most women were of Mexican heritage and in their late 20s. Eighty percent had a previous pregnancy.
"Educating patients and encouraging them to come back during visits near the termination of OB care are ways to increase the number of women who continue using health care between pregnancies," Marsiglia said. The time between pregnancies, called the interconception period, can be a time to address folic acid consumption before conception, family planning and pregnancy risks such as hypertension and diabetes.
"The program is very similar to the Comprehensive Perinatal Services Program in California that encourages educating patients throughout the antepartum period," said Peyman Banooni, M.D., an OB/GYN specialist who serves the Hispanic population in two downtown Los Angeles clinics. "Cultural sensitivity, resolving language barriers, educating patients about the system and longer health insurance coverage after delivery will definitely improve access to care and health outcomes."
However, he said "the assumption that by patients coming to postpartum visit, it will lead to better health outcomes for the patients" needs to be proven in further studies." He also said that the findings can only be applied to similar populations and not necessarily all Latino populations.
"Medical personnel are asked to do more and more and often they cannot humanly respond to all of those demands," Marsiglia said. "Cost-effective interventions like Familias Sanas can be relatively easy to implement and can significantly improve providers' and patients' outcomes."
Marsiglia FF, Bermudez-Parsai M, Coonrod D. Familias Sanas: an intervention designed to increase rates of postpartum visits among Latinas. J Health Care Poor Underserved 21(3), 2010.
Source: Health Behavior News Service
суббота, 25 июня 2011 г.
пятница, 24 июня 2011 г.
Women Need To Be Aware Of Changes, IU Simon Cancer Center Breast Expert Says
Every day, women face a barrage of headlines about breast cancer. What should they do with all of that information?
George Sledge, M.D., an internationally recognized breast cancer expert, pointed out that, despite all of the near-constant news and information about breast cancer, it is not the disease that impacts most women.
"It's important to know that, while breast cancer is a common cancer, it is not the most common cause of death in American women. Heart disease is far more common. Women need not be paralyzed by the prospect of breast cancer."
Overall, the American Cancer Society says a woman has about a one in eight chance of developing breast cancer during her lifetime. There will be 182,460 new cases of breast cancer in the United States in 2008.
Dr. Sledge, Ballve-Lantero Professor at the Indiana University School of Medicine and an oncologist and researcher at the Indiana University Melvin and Bren Simon Cancer Center, said women need to be knowledgeable - not overwhelmed - about steps they should take regarding their breasts.
For starters, women should undergo regular screening mammography, beginning at age 40.
"Fortunately, a great majority of women today are diagnosed with what we consider early-stage disease," Sledge said. "That's been a trend in recent years because of screening mammography."
Other than mammography, women need to pay attention to their bodies. "Women need to be aware of change in their breasts," Sledge added. "If they notice a lump, mass, or a new area of tenderness that they haven't noticed before, they should get that checked out promptly."
A woman should know about her family history. A woman is at greater risk of developing breast cancer if she has one of the following:
-- A personal history of breast, ovarian, or colon cancer
-- A close relative who was diagnosed with breast cancer before menopause or in both breasts
-- Never had children or who had her first child after age 30
Once detected, breast cancer is usually treated by both local therapy and systemic therapy.
In local therapy, the goal is to eliminate the cancer in the breast and the related lymph nodes and minimize the risk of recurrence. Treatment options include surgery - breast preservation, lumpectomy (removes only the breast lump and surrounding tissue), or mastectomy (removal of all breast tissue) - and radiation therapy.
Systemic therapy involves eliminating tumor cells that might have escaped into the circulation and minimizing the risk of developing distant sites of tumor growth. Treatment options include chemotherapy, hormonal therapy, and newer and an ever-expanding class of agents known as biological therapy.
"We live in an era where we have far more to offer women with breast cancer than ever before," Sledge said. "We live in an era where our ability to screen for breast cancer has gotten better than ever before. We live in an era where there's the prospect for new diagnostic and therapeutic technology for breast cancer."
George Sledge, M.D., an internationally recognized breast cancer expert, pointed out that, despite all of the near-constant news and information about breast cancer, it is not the disease that impacts most women.
"It's important to know that, while breast cancer is a common cancer, it is not the most common cause of death in American women. Heart disease is far more common. Women need not be paralyzed by the prospect of breast cancer."
Overall, the American Cancer Society says a woman has about a one in eight chance of developing breast cancer during her lifetime. There will be 182,460 new cases of breast cancer in the United States in 2008.
Dr. Sledge, Ballve-Lantero Professor at the Indiana University School of Medicine and an oncologist and researcher at the Indiana University Melvin and Bren Simon Cancer Center, said women need to be knowledgeable - not overwhelmed - about steps they should take regarding their breasts.
For starters, women should undergo regular screening mammography, beginning at age 40.
"Fortunately, a great majority of women today are diagnosed with what we consider early-stage disease," Sledge said. "That's been a trend in recent years because of screening mammography."
Other than mammography, women need to pay attention to their bodies. "Women need to be aware of change in their breasts," Sledge added. "If they notice a lump, mass, or a new area of tenderness that they haven't noticed before, they should get that checked out promptly."
A woman should know about her family history. A woman is at greater risk of developing breast cancer if she has one of the following:
-- A personal history of breast, ovarian, or colon cancer
-- A close relative who was diagnosed with breast cancer before menopause or in both breasts
-- Never had children or who had her first child after age 30
Once detected, breast cancer is usually treated by both local therapy and systemic therapy.
In local therapy, the goal is to eliminate the cancer in the breast and the related lymph nodes and minimize the risk of recurrence. Treatment options include surgery - breast preservation, lumpectomy (removes only the breast lump and surrounding tissue), or mastectomy (removal of all breast tissue) - and radiation therapy.
Systemic therapy involves eliminating tumor cells that might have escaped into the circulation and minimizing the risk of developing distant sites of tumor growth. Treatment options include chemotherapy, hormonal therapy, and newer and an ever-expanding class of agents known as biological therapy.
"We live in an era where we have far more to offer women with breast cancer than ever before," Sledge said. "We live in an era where our ability to screen for breast cancer has gotten better than ever before. We live in an era where there's the prospect for new diagnostic and therapeutic technology for breast cancer."
четверг, 23 июня 2011 г.
Women's Unique Connection To Nature Is Explored In Special Issue Of Ecopsychology
Women experience and interact with their natural surroundings in ways that differ from men. The way in which those differences affect a woman's sense of self, body image, and drive to protect and preserve the environment are explored in a thought-provoking special issue of Ecopsychology, a peer-reviewed, online journal published by Mary Ann Liebert, Inc. (liebertpub). The entire issue is available free online at liebertpub/eco
Guest Editors Britain Scott, PhD, from the University of St. Thomas (St. Paul, MN) and Lisa Lynch, PhD, from Antioch University (Seattle, WA) present a collection of articles that encompass observations and theories on how female gender, motherhood, human nature, and gender-based societal norms influence a woman's self-perception and behavior. Topics focus on what women may gain from interacting with their surroundings on a sensory level and how they may benefit from nature-based therapies.
In the article "Babes and the Woods: Women's Objectification and the Feminine Beauty Ideal as Ecological Hazards," Dr. Scott explains how cultural norms that promote a view of women as sex objects have led women to become preoccupied with, and generally critical of, their bodies. This feeling among women that they fall short of the feminine beauty ideal has a negative impact on their attitude toward, and ability to connect with, the environment.
Kari Hennigan, PhD, from Institute of Transpersonal Psychology, suggests that women who spend time in natural settings and interact with the environment are more likely to have a better body image and to distance themselves from societal definitions of beauty. Susan Logsdon-Conradsen, PhD and Sarah Allred, PhD, from Berry College (Mount Berry, GA), describe the concept of environmental mother-activism, which is based on the supposition that a woman's mothering instincts extends to a desire to protect and preserve the environmental for her children. In the article "Motherhood and Environmental Activism: A Developmental Framework," the authors propose that motherhood stimulates activist behavior, with environmental activism being one example of this transformation. Gwena?«l Salha, PhD, from Pacifica Graduate Institute (Carpinteria, CA), draws on the 4000-year-old Sumerian myth of Inanna to explore the promise of ecotherapy. In "The Heroine in the Underworld: An Ecopsychological Perspective on the Myth of Inanna," the author describes how the theme of people's perceived connections with the Earth and their local community, drawn from the myth, can be used as a model for rebuilding relationships and restoring positive communication.
"I was honored and pleased to collaborate with Lisa Lynch and Britain Scott on this special issue of Ecopsychology. In her own way, each guest editor embodies the role of ecopsychology scholar / educator and their selections highlight the promise of this exciting interdisciplinary perspective" says Editor-in-Chief Thomas Joseph Doherty, PsyD, Graduate School of Counseling, Lewis & Clark College (Portland, OR).
Source:
Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News
Guest Editors Britain Scott, PhD, from the University of St. Thomas (St. Paul, MN) and Lisa Lynch, PhD, from Antioch University (Seattle, WA) present a collection of articles that encompass observations and theories on how female gender, motherhood, human nature, and gender-based societal norms influence a woman's self-perception and behavior. Topics focus on what women may gain from interacting with their surroundings on a sensory level and how they may benefit from nature-based therapies.
In the article "Babes and the Woods: Women's Objectification and the Feminine Beauty Ideal as Ecological Hazards," Dr. Scott explains how cultural norms that promote a view of women as sex objects have led women to become preoccupied with, and generally critical of, their bodies. This feeling among women that they fall short of the feminine beauty ideal has a negative impact on their attitude toward, and ability to connect with, the environment.
Kari Hennigan, PhD, from Institute of Transpersonal Psychology, suggests that women who spend time in natural settings and interact with the environment are more likely to have a better body image and to distance themselves from societal definitions of beauty. Susan Logsdon-Conradsen, PhD and Sarah Allred, PhD, from Berry College (Mount Berry, GA), describe the concept of environmental mother-activism, which is based on the supposition that a woman's mothering instincts extends to a desire to protect and preserve the environmental for her children. In the article "Motherhood and Environmental Activism: A Developmental Framework," the authors propose that motherhood stimulates activist behavior, with environmental activism being one example of this transformation. Gwena?«l Salha, PhD, from Pacifica Graduate Institute (Carpinteria, CA), draws on the 4000-year-old Sumerian myth of Inanna to explore the promise of ecotherapy. In "The Heroine in the Underworld: An Ecopsychological Perspective on the Myth of Inanna," the author describes how the theme of people's perceived connections with the Earth and their local community, drawn from the myth, can be used as a model for rebuilding relationships and restoring positive communication.
"I was honored and pleased to collaborate with Lisa Lynch and Britain Scott on this special issue of Ecopsychology. In her own way, each guest editor embodies the role of ecopsychology scholar / educator and their selections highlight the promise of this exciting interdisciplinary perspective" says Editor-in-Chief Thomas Joseph Doherty, PsyD, Graduate School of Counseling, Lewis & Clark College (Portland, OR).
Source:
Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News
Lapatinib Shows Promise As Therapy For Inflammatory Breast Cancer, Study Finds
In the first multi-center and international clinical trial conducted to better understand the complexities of a rare, aggressive and often lethal form of breast cancer, researchers have discovered that the experimental biological agent, lapatinib, successfully and specifically treats inflammatory breast cancer (IBC).
Massimo Cristofanilli, M.D., associate professor in the Department of Breast Medical Oncology at The University of Texas M. D. Anderson Cancer Center, reported the findings of the international Phase II trial at the San Antonio Breast Cancer Symposium.
IBC is rare, representing just 1- 2 percent of all breast cancers diagnosed. Unlike other breast cancers that present as a lump, IBC??™s symptoms include redness, swelling, and warmth in the breast, skin that is reddish, purple or bruised, has ridges and/or appears pitted like an orange. Other symptoms can include burning, aching or tenderness, an increase in breast size, and/or an inverted nipple.
A fast growing and aggressive cancer, IBC is more likely than other breast cancers to be misdiagnosed, often diagnosed after the disease has metastasized, says Cristofanilli. According to Cristofanilli, 40 percent of women with IBC will survive five years. Until now, no therapies specific to IBC have been studied in multi-center trials. As a consequence, no effective therapies - standard or experimental - exist for women with IBC.
???We initiated this Phase II study because lapatinib is one of the few drugs that had shown any activity in Phase I studies in patients with recurrent IBC. It appeared that this agent could be the first to offer hope for women newly diagnosed with the disease,??? says Cristofanilli, the study??™s principal investigator.
Lapatinib is an epidermal growth factor receptor and HER2neu tyrosine kinase inhibitor. An experimental drug that has shown promise in patients with metastatic HER2-positive cancer in whom Herceptin has failed, the oral agent blocks the activity of the HER2 protein as well as EGFR by binding to the part of the protein found inside breast cancer cells, explains Cristofanilli.
The trial enrolled 49 newly diagnosed IBC patients, all of whom were HER2 and/or EGFR-positive and who had never been treated for their disease. Approximately 25 percent of the women had metastatic disease.
The women received two weeks of daily lapatinib alone, followed by three months of concurrent lapatinib (taken daily) and paclitaxel chemotherapy (given weekly). Thirty-five of the patients completed the trial and had surgery, as indicated by the protocol, and constitutes the data presented.
The study reports that 30 out of the 35 patients, or 86 percent, had a clinical response, defined as 50 percent reduction in tumor size, to the lapatinib-chemotherapy drug regimen. Only one patient progressed during therapy. Three of the first 21 patients that had surgery had a complete pathological response, meaning that there was no evidence of disease at the time of surgery.
Just as interesting and important is the finding that 25-30 percent of the patients responded in the first two weeks when receiving lapatinib alone, says Cristofanilli.
???For IBC patients, these results should be very encouraging because there??™s now more of a dedicated research effort for a type of breast cancer that has long been ignored and misunderstood. With lapatinib, we finally have a drug on which to build effective therapy - we just have to refine the most effective way to use it. The findings presented today will allow us to expedite future clinical trials.???
Planned studies with laptinib likely will include the agent in combination with different chemotherapy regimens. The trials also will focus on IBC patients who are HER2-positive, not EGFR positive, as indications from the Phase II trial showed that IBC patients who were HER2 positive responded better to the laptinib therapy.
Side effects to the laptinib were predictable and manageable, with diarrhea and a skin rash being the most common, he says.
In October, M. D. Anderson opened the first center in the world dedicated to IBC treatment and research. The clinic is under the co-direction of Cristofanilli and Thomas Buchholz, M.D., professor in the Department of Radiation Oncology, and is housed in M. D. Anderson??™s Nellie B. Connally Breast Center.
Already, M. D. Anderson sees approximately 30 new cases of IBC a year - more than any other institution in this country, says Cristofanilli. With the new clinic, Cristofanilli and his team hope to see 60-80 new cases annually. Lapatinib is manufactured by GlaxoSmithKline.
Contact: Julie Penne
University of Texas M. D. Anderson Cancer Center
View drug information on Herceptin.
Massimo Cristofanilli, M.D., associate professor in the Department of Breast Medical Oncology at The University of Texas M. D. Anderson Cancer Center, reported the findings of the international Phase II trial at the San Antonio Breast Cancer Symposium.
IBC is rare, representing just 1- 2 percent of all breast cancers diagnosed. Unlike other breast cancers that present as a lump, IBC??™s symptoms include redness, swelling, and warmth in the breast, skin that is reddish, purple or bruised, has ridges and/or appears pitted like an orange. Other symptoms can include burning, aching or tenderness, an increase in breast size, and/or an inverted nipple.
A fast growing and aggressive cancer, IBC is more likely than other breast cancers to be misdiagnosed, often diagnosed after the disease has metastasized, says Cristofanilli. According to Cristofanilli, 40 percent of women with IBC will survive five years. Until now, no therapies specific to IBC have been studied in multi-center trials. As a consequence, no effective therapies - standard or experimental - exist for women with IBC.
???We initiated this Phase II study because lapatinib is one of the few drugs that had shown any activity in Phase I studies in patients with recurrent IBC. It appeared that this agent could be the first to offer hope for women newly diagnosed with the disease,??? says Cristofanilli, the study??™s principal investigator.
Lapatinib is an epidermal growth factor receptor and HER2neu tyrosine kinase inhibitor. An experimental drug that has shown promise in patients with metastatic HER2-positive cancer in whom Herceptin has failed, the oral agent blocks the activity of the HER2 protein as well as EGFR by binding to the part of the protein found inside breast cancer cells, explains Cristofanilli.
The trial enrolled 49 newly diagnosed IBC patients, all of whom were HER2 and/or EGFR-positive and who had never been treated for their disease. Approximately 25 percent of the women had metastatic disease.
The women received two weeks of daily lapatinib alone, followed by three months of concurrent lapatinib (taken daily) and paclitaxel chemotherapy (given weekly). Thirty-five of the patients completed the trial and had surgery, as indicated by the protocol, and constitutes the data presented.
The study reports that 30 out of the 35 patients, or 86 percent, had a clinical response, defined as 50 percent reduction in tumor size, to the lapatinib-chemotherapy drug regimen. Only one patient progressed during therapy. Three of the first 21 patients that had surgery had a complete pathological response, meaning that there was no evidence of disease at the time of surgery.
Just as interesting and important is the finding that 25-30 percent of the patients responded in the first two weeks when receiving lapatinib alone, says Cristofanilli.
???For IBC patients, these results should be very encouraging because there??™s now more of a dedicated research effort for a type of breast cancer that has long been ignored and misunderstood. With lapatinib, we finally have a drug on which to build effective therapy - we just have to refine the most effective way to use it. The findings presented today will allow us to expedite future clinical trials.???
Planned studies with laptinib likely will include the agent in combination with different chemotherapy regimens. The trials also will focus on IBC patients who are HER2-positive, not EGFR positive, as indications from the Phase II trial showed that IBC patients who were HER2 positive responded better to the laptinib therapy.
Side effects to the laptinib were predictable and manageable, with diarrhea and a skin rash being the most common, he says.
In October, M. D. Anderson opened the first center in the world dedicated to IBC treatment and research. The clinic is under the co-direction of Cristofanilli and Thomas Buchholz, M.D., professor in the Department of Radiation Oncology, and is housed in M. D. Anderson??™s Nellie B. Connally Breast Center.
Already, M. D. Anderson sees approximately 30 new cases of IBC a year - more than any other institution in this country, says Cristofanilli. With the new clinic, Cristofanilli and his team hope to see 60-80 new cases annually. Lapatinib is manufactured by GlaxoSmithKline.
Contact: Julie Penne
University of Texas M. D. Anderson Cancer Center
View drug information on Herceptin.
Ontario Women Live Longer But Don't Prosper: Study
While Ontario women live longer than men, a majority are more likely to suffer from disability and chronic conditions, according to a new women's health study by St. Michael's Hospital researcher Dr. Arlene Bierman. What's more, low-income women have more chronic conditions, greater disability and a shorter life expectancy than women in high-income groups.
While inequities in health among men and women have been well documented, the findings strongly suggest that the size of the inequities among women is often larger than the overall differences between men and women.
"Women with less education and low income were found to experience a greater burden of illness overall compared to men and women with higher incomes," said Dr. Bierman. "While we already knew these inequities exist, we are quite startled by just how large the gap is among different groups of women. The good news is that there is much that can be done to close this gap. The inequities we found are associated with chronic disease, so by focusing on chronic disease prevention and management, and improving the living and working conditions that increase the risk of chronic disease, we can improve health outcomes for all women and men."
The joint study, titled POWER (the Project for an Ontario Women's Health Evidence-Based Report), from St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES), is the first in Ontario to provide a comprehensive overview of women's health in relation to gender, income, education, ethnicity and geography. POWER reports on indicators of population health and of how well the health system is performing. Policymakers and health-care providers may use these research findings to improve access, quality and outcomes of care for Ontario women. The POWER Study was funded by Echo: Improving Women's Health in Ontario, an agency of the Ontario Ministry of Health and Long-Term Care.
Key findings released include:
Chronic conditions
* The majority of women and men in Ontario have at least one chronic condition and many have two or more.
* Thirty-nine per cent of low income women have two or more chronic conditions compared to 28 per cent of women in the highest income group and 21 per cent of higher income men.
* Among women aged 65 and older, 70 per cent of low-income women have two or more chronic conditions compared to 57 per cent of higher-income women and 50 per cent of higher-income men.
Disease risk factors
* Overall, more than half of Ontario adults age 25 years and older reported physical inactivity (51 per cent) and inadequate fruit and vegetable intake (57 per cent), 53 per cent were overweight or obese and 22 per cent were current smokers
* Women are less physically active than men, but eat more fruits and vegetables, and are less likely to be overweight or obese and smoke than men.
* While rates of smoking have decreased over time, 28 per cent of women with less than a high school education report smoking compared to eight per cent of women who had a university degree or higher.
Length of Life
* Low-income women and men are more likely to die prematurely.
* Twenty-six per cent of women and 41 per cent of men in the lowest income range die before age 75 compared to 19 per cent of women and 28 per cent of men in the highest income bracket.
Pain
* Thirty-five per cent of low income women age 65 and older say their activities are limited by pain compared to 18 per cent of higher income women in this age group.
* Among women age 25-64, 26 per cent of low income women, and 10 per cent of higher income women report their activities are limited by pain.
Disabilities
* More than half of low-income women age 65 and older have a disability that requires the help of another person to carry out routine daily activities such as grocery shopping, housework and meal preparation.
* Older women are also about 50 per cent more likely than older men to be admitted to hospital for a fall-related injury, which can result in long-term disability and health problems.
Low income
* Across all age groups, women are more likely to live in lower-income households than men, with gender differences in income greatest among those age 65 years and older.
* Forty-four percent of women age 65-79 and 52 per cent of those aged 80 and older reported lower income compared to 33 per cent and 35 per cent of men in these age groups, respectively.
Common modifiable risk factors such as smoking, diet, and lack of exercise are responsible for much of the chronic illnesses present in both women and men. Chronic diseases are estimated to account for 87 per cent of disability in Canada.
According to the researchers, socioeconomic factors including income, education, housing, and environment as well as health behaviours must be addressed to eliminate the gap and improve population health. The POWER Study recommends:
* A comprehensive chronic disease prevention and management strategy that involves both community-based and health-sector interventions
* Better co-ordination of population-based health promotion, community-based services and clinical care services aimed at improving health among Ontarians
* Incorporation of gender and equity into health indicator reporting and monitoring to reduce disparities in health and health care.
"We must improve our knowledge of the diverse health needs of Ontario women. The POWER Study is a huge step in that direction," said Pat Campbell, CEO of ECHO. "By monitoring our progress in improving health outcomes and reducing disparities, there will be better care for women and more equitable care to all Ontarians. The findings of the study will provide strong evidence to inform priority setting and provide a baseline from which to measure progress in women's health."
Notes:
For more information on the POWER Study and to access the burden of illness report, visit powerstudy.
Dr. Arlene Bierman is a researcher in the Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital, a scientist at ICES and Echo's Ontario Women's Health Council Chair in Women's Health at St. Michaels Hospital and the University of Toronto (Lawrence S. Bloomberg Faculty of Nursing).
Source:
Julie Saccone
St. Michael's Hospital
While inequities in health among men and women have been well documented, the findings strongly suggest that the size of the inequities among women is often larger than the overall differences between men and women.
"Women with less education and low income were found to experience a greater burden of illness overall compared to men and women with higher incomes," said Dr. Bierman. "While we already knew these inequities exist, we are quite startled by just how large the gap is among different groups of women. The good news is that there is much that can be done to close this gap. The inequities we found are associated with chronic disease, so by focusing on chronic disease prevention and management, and improving the living and working conditions that increase the risk of chronic disease, we can improve health outcomes for all women and men."
The joint study, titled POWER (the Project for an Ontario Women's Health Evidence-Based Report), from St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES), is the first in Ontario to provide a comprehensive overview of women's health in relation to gender, income, education, ethnicity and geography. POWER reports on indicators of population health and of how well the health system is performing. Policymakers and health-care providers may use these research findings to improve access, quality and outcomes of care for Ontario women. The POWER Study was funded by Echo: Improving Women's Health in Ontario, an agency of the Ontario Ministry of Health and Long-Term Care.
Key findings released include:
Chronic conditions
* The majority of women and men in Ontario have at least one chronic condition and many have two or more.
* Thirty-nine per cent of low income women have two or more chronic conditions compared to 28 per cent of women in the highest income group and 21 per cent of higher income men.
* Among women aged 65 and older, 70 per cent of low-income women have two or more chronic conditions compared to 57 per cent of higher-income women and 50 per cent of higher-income men.
Disease risk factors
* Overall, more than half of Ontario adults age 25 years and older reported physical inactivity (51 per cent) and inadequate fruit and vegetable intake (57 per cent), 53 per cent were overweight or obese and 22 per cent were current smokers
* Women are less physically active than men, but eat more fruits and vegetables, and are less likely to be overweight or obese and smoke than men.
* While rates of smoking have decreased over time, 28 per cent of women with less than a high school education report smoking compared to eight per cent of women who had a university degree or higher.
Length of Life
* Low-income women and men are more likely to die prematurely.
* Twenty-six per cent of women and 41 per cent of men in the lowest income range die before age 75 compared to 19 per cent of women and 28 per cent of men in the highest income bracket.
Pain
* Thirty-five per cent of low income women age 65 and older say their activities are limited by pain compared to 18 per cent of higher income women in this age group.
* Among women age 25-64, 26 per cent of low income women, and 10 per cent of higher income women report their activities are limited by pain.
Disabilities
* More than half of low-income women age 65 and older have a disability that requires the help of another person to carry out routine daily activities such as grocery shopping, housework and meal preparation.
* Older women are also about 50 per cent more likely than older men to be admitted to hospital for a fall-related injury, which can result in long-term disability and health problems.
Low income
* Across all age groups, women are more likely to live in lower-income households than men, with gender differences in income greatest among those age 65 years and older.
* Forty-four percent of women age 65-79 and 52 per cent of those aged 80 and older reported lower income compared to 33 per cent and 35 per cent of men in these age groups, respectively.
Common modifiable risk factors such as smoking, diet, and lack of exercise are responsible for much of the chronic illnesses present in both women and men. Chronic diseases are estimated to account for 87 per cent of disability in Canada.
According to the researchers, socioeconomic factors including income, education, housing, and environment as well as health behaviours must be addressed to eliminate the gap and improve population health. The POWER Study recommends:
* A comprehensive chronic disease prevention and management strategy that involves both community-based and health-sector interventions
* Better co-ordination of population-based health promotion, community-based services and clinical care services aimed at improving health among Ontarians
* Incorporation of gender and equity into health indicator reporting and monitoring to reduce disparities in health and health care.
"We must improve our knowledge of the diverse health needs of Ontario women. The POWER Study is a huge step in that direction," said Pat Campbell, CEO of ECHO. "By monitoring our progress in improving health outcomes and reducing disparities, there will be better care for women and more equitable care to all Ontarians. The findings of the study will provide strong evidence to inform priority setting and provide a baseline from which to measure progress in women's health."
Notes:
For more information on the POWER Study and to access the burden of illness report, visit powerstudy.
Dr. Arlene Bierman is a researcher in the Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital, a scientist at ICES and Echo's Ontario Women's Health Council Chair in Women's Health at St. Michaels Hospital and the University of Toronto (Lawrence S. Bloomberg Faculty of Nursing).
Source:
Julie Saccone
St. Michael's Hospital
January 2008 AJPH Highlights: Poverty And Human Development
The articles below will be published online Nov.29, 2007, at 4 p.m. (EDT) by the American Journal of Public Health under "First Look" at ajph/first_look.shtml, and will appear in the January 2008 print issue of the Journal. The January 2008 issue is participating in the Global Theme Issue on Poverty and Human Development, organized by the Council of Science Editors. "First Look" articles have undergone peer review, copyediting and approval by authors but have not yet been printed to paper or posted online by issue. The American Journal of Public Health is published by the American Public Health Association, apha, and is available at ajph.
Immigrant children at higher risk of lead poisoning
Foreign-born children were five times more likely to have elevated blood lead levels than were U.S.-born children.
Researchers conducted a study among children in New York City to investigate associations of childhood lead poisoning with birth and residence in a foreign country. After controlling for housing characteristics and child behaviors such as eating non-food items, data suggested that foreign-born children were five times more likely than were U.S.-born children to have elevated blood lead levels. In addition, children living abroad within 6 months of their blood test had a 10-times increased risk for lead poisoning relative to U.S.-born children with no history of foreign residence.
"These results suggest a need for considering recent immigration as a risk factor for childhood lead poisoning and allocating resources to identify and remove lead exposure sources in the immigrant communities at greater risk," said the study's authors. "Equally important is educating immigrant families about methods of reducing children's exposure to lead paint hazards, given that paint may be an unfamiliar source for many immigrant families." [From: "Immigration and Risk of Childhood Lead Poisoning: Findings From a Case-Control Study of New York City Children." ]
Nearly 60 percent of women trafficked and sexually exploited suffered from posttraumatic stress
Study is first to quantitatively document the health symptoms of trafficked women and adolescent girls in Europe.
Researchers interviewed 192 women and adolescent girls within 14 days of accessing post-trafficking services to investigate the health of women trafficked for sexual exploitation in Europe. Almost 60 percent of participants reported experiences of sexual or physical violence before being trafficked, and 12 percent had a forced or coerced sexual experience before the age of 15. Ninety-five percent of participants reported physical or sexual violence while in the trafficking situation. Symptoms associated with depression were most often reported, with 39 percent of participants acknowledging having suicidal thoughts within the past seven days.
"The severe symptom patterns identified suggest that diagnostic and treatment services should be made immediately available to survivors of trafficking," said the study's authors. "However, dissecting the constellation of women's symptoms and formulating treatment plans are not likely to be easy or short-term tasks." [From: "The Health of Trafficked Women: A Survey of Women Entering Post-trafficking Services in Europe." ]
Increased health care spending in developing countries not enough by itself to increase utilization of skilled birth attendants
Access to education, however, contributes to birth attendant use, so the optimal scenario in a country combines higher health care expenditures and equitable access policies.
The study analyzed data from Demographic and Health Surveys of 45 developing countries to investigate the extent to which redistributive education policies modify the impact of higher health spending on the utilization of skilled birth attendants among the poorest compared with the least poor women. Data suggests that at any given level of health care spending, women's use of skilled birth attendants varied substantially, depending on the equity of distribution of education.
"This work supports the thesis that higher levels of health expenditure do not automatically mean substantially greater use of skilled birth attendants by poor women," said the study's authors. "Poor women's access to education, which is in the domain of government policy and reflects a redistributive policy environment, is an important influence on improving the equity of access." [From: "Equity of Skilled Birth Attendant Utilization in Developing Countries: Financing and Policy Determinants." ]
Early and late sexual debut associated with problems in sexual functioning
Early initiation of sexual intercourse is associated with increased number of sexual partners, increased sexual risk behaviors and problems in sexual functioning.
Researchers examined the adult consequences of early or late sexual debut by conducting a secondary analysis of data from the National Sexual Health Survey. Researchers also compared individuals whose first sexual intercourse occurred after marriage with those whose first experience occurred before marriage.
Data suggested that timing of first sexual intercourse was associated with several sexual risk factors in men and women. Men and women who had an early sexual debut reported more sexual partners, were more likely to have had sexual intercourse with at least one risky partner in the preceding year and preceding five years and were more likely to have had sexual intercourse under the influence of alcohol or drugs in the past year. When compared to those who debuted at a normative age, early starters were more likely to have a history of an STI, whereas late starting women were less likely than those who had started at a normative age to have such a history. Early initiation and late initiation were both associated with various problems in sexual functioning, especially in men. Differences observed between individuals whose first sexual intercourse occurred before marriage and those whose first intercourse occurred after marriage were similar to those observed between early and late starters.
"Although our findings support an association between early initiation and long-term STI risk, they also suggest a more complicated picture of sexual functioning. Contrary to the suggestions of proponents of abstinence-only education, we found that both early and late initiators are more likely to experience problems with sexual functioning than those who initiate sexual activity at a normative age," said the study's authors. "Such a finding in regard to late initiation lends credence to research showing that abstinence-only education may actually increase health risks and that strategies designed to promote relevant sexual health information, motivation and skills are likely to be more effective than abstinence-only messages in helping young people avoid short- as well as long-term health consequences." [From: "Long-term Health Consequences of Timing of Sexual Debut: Results from a National U.S. Study" by Sandfort, Orr, Hirsch & Santelli; ]
The American Journal of Public Health is the monthly journal of the American Public Health Association (APHA), the oldest organization of public health professionals in the world. APHA is a leading publisher of books and periodicals promoting sound scientific standards, action programs and public policy to enhance health. More information is available at apha.
American Public Health Association (APHA)
800 I St. NW
Washington, DC 20001
United States
ajph
Immigrant children at higher risk of lead poisoning
Foreign-born children were five times more likely to have elevated blood lead levels than were U.S.-born children.
Researchers conducted a study among children in New York City to investigate associations of childhood lead poisoning with birth and residence in a foreign country. After controlling for housing characteristics and child behaviors such as eating non-food items, data suggested that foreign-born children were five times more likely than were U.S.-born children to have elevated blood lead levels. In addition, children living abroad within 6 months of their blood test had a 10-times increased risk for lead poisoning relative to U.S.-born children with no history of foreign residence.
"These results suggest a need for considering recent immigration as a risk factor for childhood lead poisoning and allocating resources to identify and remove lead exposure sources in the immigrant communities at greater risk," said the study's authors. "Equally important is educating immigrant families about methods of reducing children's exposure to lead paint hazards, given that paint may be an unfamiliar source for many immigrant families." [From: "Immigration and Risk of Childhood Lead Poisoning: Findings From a Case-Control Study of New York City Children." ]
Nearly 60 percent of women trafficked and sexually exploited suffered from posttraumatic stress
Study is first to quantitatively document the health symptoms of trafficked women and adolescent girls in Europe.
Researchers interviewed 192 women and adolescent girls within 14 days of accessing post-trafficking services to investigate the health of women trafficked for sexual exploitation in Europe. Almost 60 percent of participants reported experiences of sexual or physical violence before being trafficked, and 12 percent had a forced or coerced sexual experience before the age of 15. Ninety-five percent of participants reported physical or sexual violence while in the trafficking situation. Symptoms associated with depression were most often reported, with 39 percent of participants acknowledging having suicidal thoughts within the past seven days.
"The severe symptom patterns identified suggest that diagnostic and treatment services should be made immediately available to survivors of trafficking," said the study's authors. "However, dissecting the constellation of women's symptoms and formulating treatment plans are not likely to be easy or short-term tasks." [From: "The Health of Trafficked Women: A Survey of Women Entering Post-trafficking Services in Europe." ]
Increased health care spending in developing countries not enough by itself to increase utilization of skilled birth attendants
Access to education, however, contributes to birth attendant use, so the optimal scenario in a country combines higher health care expenditures and equitable access policies.
The study analyzed data from Demographic and Health Surveys of 45 developing countries to investigate the extent to which redistributive education policies modify the impact of higher health spending on the utilization of skilled birth attendants among the poorest compared with the least poor women. Data suggests that at any given level of health care spending, women's use of skilled birth attendants varied substantially, depending on the equity of distribution of education.
"This work supports the thesis that higher levels of health expenditure do not automatically mean substantially greater use of skilled birth attendants by poor women," said the study's authors. "Poor women's access to education, which is in the domain of government policy and reflects a redistributive policy environment, is an important influence on improving the equity of access." [From: "Equity of Skilled Birth Attendant Utilization in Developing Countries: Financing and Policy Determinants." ]
Early and late sexual debut associated with problems in sexual functioning
Early initiation of sexual intercourse is associated with increased number of sexual partners, increased sexual risk behaviors and problems in sexual functioning.
Researchers examined the adult consequences of early or late sexual debut by conducting a secondary analysis of data from the National Sexual Health Survey. Researchers also compared individuals whose first sexual intercourse occurred after marriage with those whose first experience occurred before marriage.
Data suggested that timing of first sexual intercourse was associated with several sexual risk factors in men and women. Men and women who had an early sexual debut reported more sexual partners, were more likely to have had sexual intercourse with at least one risky partner in the preceding year and preceding five years and were more likely to have had sexual intercourse under the influence of alcohol or drugs in the past year. When compared to those who debuted at a normative age, early starters were more likely to have a history of an STI, whereas late starting women were less likely than those who had started at a normative age to have such a history. Early initiation and late initiation were both associated with various problems in sexual functioning, especially in men. Differences observed between individuals whose first sexual intercourse occurred before marriage and those whose first intercourse occurred after marriage were similar to those observed between early and late starters.
"Although our findings support an association between early initiation and long-term STI risk, they also suggest a more complicated picture of sexual functioning. Contrary to the suggestions of proponents of abstinence-only education, we found that both early and late initiators are more likely to experience problems with sexual functioning than those who initiate sexual activity at a normative age," said the study's authors. "Such a finding in regard to late initiation lends credence to research showing that abstinence-only education may actually increase health risks and that strategies designed to promote relevant sexual health information, motivation and skills are likely to be more effective than abstinence-only messages in helping young people avoid short- as well as long-term health consequences." [From: "Long-term Health Consequences of Timing of Sexual Debut: Results from a National U.S. Study" by Sandfort, Orr, Hirsch & Santelli; ]
The American Journal of Public Health is the monthly journal of the American Public Health Association (APHA), the oldest organization of public health professionals in the world. APHA is a leading publisher of books and periodicals promoting sound scientific standards, action programs and public policy to enhance health. More information is available at apha.
American Public Health Association (APHA)
800 I St. NW
Washington, DC 20001
United States
ajph
Experimental Microbicide Gel Offers Some Protection Against HIV Transmission, Study Finds
An experimental vaginal microbicide gel shows a small level of protection against HIV transmission, according to a study presented Monday at the ongoing 16th Conference on Retroviruses and Opportunistic Infections in Montreal, Canada, the Washington Post reports (Brown, Washington Post, 2/10). The gel, called PRO 2000 and manufactured by Indevus Pharmaceuticals, is designed to prevent HIV from attaching to certain white blood cells. According to the study -- which primarily aimed to test the gel's safety -- the PRO 2000 gel is 30% effective in preventing HIV transmission. Although the findings might be inconclusive, the study is the first to demonstrate a possible beneficial effect from using microbicides (Stobbe, AP/Google, 2/9). Researchers for many years have worked to develop effective microbicides to prevent HIV transmission, but no earlier studies have shown promising results, and two previous trials showed that the gels being studied actually increased the risk of contracting HIV. According to the Post, because microbicides can be applied without the knowledge of sexual partners, they are considered "especially important in cultures where the subservient status of women makes it difficult for them to insist on abstinence or condom use" (Washington Post, 2/10).
For the study, Salim Abdool Karim of the Center for the AIDS Program of Research in South Africa and colleagues divided 3,100 women from Malawi, South Africa, the U.S., Zambia and Zimbabwe into four groups. They provided the first group of women with the PRO 2000 gel; the second with ReProtect's microbicide gel BufferGel; the third group with a placebo gel; and the remaining group with no microbicide gel. All the women received counseling to encourage condom use (AP/Google, 2/9). At the conclusion of the 20-month study period, 194 women had contracted HIV, including 36 women from the PRO 2000 group, 54 from the BufferGel group, 51 from the placebo group and 53 from the group that used no microbicides. Although the PRO 2000 gel was 30% effective, the researchers noted that the results are not statistically significant (Reichard, CQ HealthBeat, 2/9). According to the National Institutes of Health, which funded the study, an effectiveness rate of 33% would be statistically significant (AFP/Google, 2/9). The researchers also found no significant indication that BufferGel protected against HIV transmission (Fox, Reuters, 2/9).
Although the results of the Indevus trial show promise, the study did not provide data on the percentage of cases in which PRO 2000 was effective if actually applied. According to NIH, participants reported use of the gels in 81% of sex acts. Kathy Stover, NIH communications officer, said the study was based on self-reporting, and therefore the researchers "have no way to verify that the gel was actually applied prior to sexual intercourse" (CQ HealthBeat, 2/9). According to health officials, further research will be necessary to determine the gel's efficacy. London's Medical Research Council currently is conducting a study of the PRO 2000 gel involving 9,500 women, which is three times the size of the first study, Bloomberg reports. Mitchell Warren, executive director of the AIDS Vaccine Advocacy Coalition, said the "positive" result from the first trial "increases the anticipation of those from the next" (Lauerman, Bloomberg, 2/9).
Karim, who presented the PRO 2000 study at the conference, said the gel "could be a niche product for a group of women who have no other option." In sub-Saharan Africa, about 60% of HIV-positive people are women, the Post reports. (Washington Post, 2/10). Karim added that the study, "while not conclusive, provides a glimmer of hope to millions of women at risk for HIV, especially young women in Africa." Anthony Fauci, director of NIH's National Institute of Allergy and Infectious Diseases, added, "An effective microbicide would be a valuable tool that women could use to protect themselves against HIV and one that could substantially reduce the number of new HIV infections worldwide (AFP/Google, 2/9).
Reprinted with kind permission from nationalpartnership. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
For the study, Salim Abdool Karim of the Center for the AIDS Program of Research in South Africa and colleagues divided 3,100 women from Malawi, South Africa, the U.S., Zambia and Zimbabwe into four groups. They provided the first group of women with the PRO 2000 gel; the second with ReProtect's microbicide gel BufferGel; the third group with a placebo gel; and the remaining group with no microbicide gel. All the women received counseling to encourage condom use (AP/Google, 2/9). At the conclusion of the 20-month study period, 194 women had contracted HIV, including 36 women from the PRO 2000 group, 54 from the BufferGel group, 51 from the placebo group and 53 from the group that used no microbicides. Although the PRO 2000 gel was 30% effective, the researchers noted that the results are not statistically significant (Reichard, CQ HealthBeat, 2/9). According to the National Institutes of Health, which funded the study, an effectiveness rate of 33% would be statistically significant (AFP/Google, 2/9). The researchers also found no significant indication that BufferGel protected against HIV transmission (Fox, Reuters, 2/9).
Although the results of the Indevus trial show promise, the study did not provide data on the percentage of cases in which PRO 2000 was effective if actually applied. According to NIH, participants reported use of the gels in 81% of sex acts. Kathy Stover, NIH communications officer, said the study was based on self-reporting, and therefore the researchers "have no way to verify that the gel was actually applied prior to sexual intercourse" (CQ HealthBeat, 2/9). According to health officials, further research will be necessary to determine the gel's efficacy. London's Medical Research Council currently is conducting a study of the PRO 2000 gel involving 9,500 women, which is three times the size of the first study, Bloomberg reports. Mitchell Warren, executive director of the AIDS Vaccine Advocacy Coalition, said the "positive" result from the first trial "increases the anticipation of those from the next" (Lauerman, Bloomberg, 2/9).
Karim, who presented the PRO 2000 study at the conference, said the gel "could be a niche product for a group of women who have no other option." In sub-Saharan Africa, about 60% of HIV-positive people are women, the Post reports. (Washington Post, 2/10). Karim added that the study, "while not conclusive, provides a glimmer of hope to millions of women at risk for HIV, especially young women in Africa." Anthony Fauci, director of NIH's National Institute of Allergy and Infectious Diseases, added, "An effective microbicide would be a valuable tool that women could use to protect themselves against HIV and one that could substantially reduce the number of new HIV infections worldwide (AFP/Google, 2/9).
Reprinted with kind permission from nationalpartnership. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
Подписаться на:
Сообщения (Atom)